Chenkai Huang

686 total citations
26 papers, 517 citations indexed

About

Chenkai Huang is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Chenkai Huang has authored 26 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Hepatology and 8 papers in Molecular Biology. Recurrent topics in Chenkai Huang's work include Liver Disease Diagnosis and Treatment (16 papers), Liver physiology and pathology (7 papers) and Liver Disease and Transplantation (6 papers). Chenkai Huang is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Liver physiology and pathology (7 papers) and Liver Disease and Transplantation (6 papers). Chenkai Huang collaborates with scholars based in China, United States and Taiwan. Chenkai Huang's co-authors include Xuan Zhu, Sizhe Wan, Anjiang Wang, Yuan Nie, Bimin Li, Wang Zhang, Wei‐Fen Xie, Wang Zhang, Wenhua He and Chen‐Hong Ding and has published in prestigious journals such as Nature Communications, Gut and The FASEB Journal.

In The Last Decade

Chenkai Huang

23 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenkai Huang China 14 255 225 143 90 76 26 517
Hongyao Liu China 11 191 0.7× 133 0.6× 112 0.8× 53 0.6× 39 0.5× 30 551
Chanbin Lee South Korea 13 222 0.9× 297 1.3× 149 1.0× 83 0.9× 35 0.5× 24 626
Xiong Cai China 13 222 0.9× 202 0.9× 154 1.1× 77 0.9× 73 1.0× 31 657
Hsiao‐Yen Ma United States 14 212 0.8× 218 1.0× 167 1.2× 43 0.5× 50 0.7× 18 583
Siwei Xia China 14 222 0.9× 184 0.8× 92 0.6× 96 1.1× 44 0.6× 30 537
Weiguang Ren China 10 124 0.5× 153 0.7× 92 0.6× 52 0.6× 31 0.4× 24 333
Mao‐xu Ge China 11 133 0.5× 157 0.7× 123 0.9× 26 0.3× 58 0.8× 15 357
Karim Hamesch Germany 8 171 0.7× 245 1.1× 228 1.6× 56 0.6× 130 1.7× 26 661
Yang Cheng China 14 331 1.3× 144 0.6× 59 0.4× 206 2.3× 40 0.5× 36 606

Countries citing papers authored by Chenkai Huang

Since Specialization
Citations

This map shows the geographic impact of Chenkai Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenkai Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenkai Huang more than expected).

Fields of papers citing papers by Chenkai Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenkai Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenkai Huang. The network helps show where Chenkai Huang may publish in the future.

Co-authorship network of co-authors of Chenkai Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Chenkai Huang. A scholar is included among the top collaborators of Chenkai Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenkai Huang. Chenkai Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Chenkai, Hui Qian, Chen‐Hong Ding, et al.. (2025). Positive feedback between arginine methylation of YAP and methionine transporter SLC43A2 drives anticancer drug resistance. Nature Communications. 16(1). 87–87. 6 indexed citations
2.
Li, Bimin, et al.. (2025). MFAP4 Deficiency Attenuates Liver Fibrosis by Regulating Hepatic Stellate Cell Fate Through Inhibition of the FAK/PI3K/NFκB Signaling Pathway. Cellular and Molecular Gastroenterology and Hepatology. 19(10). 101548–101548. 1 indexed citations
3.
Zhang, Yue, et al.. (2025). Ursolic acid alleviates liver fibrosis by regulating Hepatic stellate cell activation via the Notch3/NOX4 pathway. Chemico-Biological Interactions. 418. 111612–111612.
4.
Qian, Hui, Chen‐Hong Ding, Fang Liu, et al.. (2024). SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumors. Signal Transduction and Targeted Therapy. 9(1). 96–96. 8 indexed citations
5.
Liu, Lingxiang, Bimin Li, Wang Zhang, et al.. (2024). Exploring the mechanism of ursolic acid in preventing liver fibrosis and improving intestinal microbiota based on NOX2/NLRP3 inflammasome signaling pathway. Chemico-Biological Interactions. 405. 111305–111305. 3 indexed citations
6.
Zhang, Yue, et al.. (2024). LHPP deficiency aggravates liver fibrosis through TGF‐β/Smad3 signaling. The FASEB Journal. 38(19). e70053–e70053.
7.
Li, Yu, Chenkai Huang, Yi Hu, et al.. (2024). Exploring the performance of large language models on hepatitis B infection-related questions: A comparative study. World Journal of Gastroenterology. 31(3). 101092–101092. 4 indexed citations
8.
Huang, Chenkai, et al.. (2023). Photoresponse of Graphene Channel in Graphene-Oxide–Silicon Photodetectors. Photonics. 10(5). 568–568.
9.
Zhang, Wang, Chenkai Huang, Jie Jian, et al.. (2022). Ursolic acid alleviates Kupffer cells pyroptosis in liver fibrosis by the NOX2/NLRP3 inflammasome signaling pathway. International Immunopharmacology. 113(Pt A). 109321–109321. 23 indexed citations
10.
11.
Sun, Qin-Juan, Jie Jian, Chenkai Huang, et al.. (2021). The Role of Bone Morphogenetic Protein 9 in Nonalcoholic Fatty Liver Disease in Mice. Frontiers in Pharmacology. 11. 605967–605967. 19 indexed citations
12.
Zhang, Yue, et al.. (2021). Soluble CD163 Is a Predictor of Mortality in Patients With Decompensated Cirrhosis. Frontiers in Medicine. 8. 698502–698502. 5 indexed citations
13.
Qian, Hui, Chenkai Huang, Fang Liu, et al.. (2021). Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy. European Journal of Pharmacology. 906. 174217–174217. 11 indexed citations
14.
Wan, Sizhe, Yuan Nie, Yue Zhang, Chenkai Huang, & Xuan Zhu. (2020). Gut Microbial Dysbiosis Is Associated With Profibrotic Factors in Liver Fibrosis Mice. Frontiers in Cellular and Infection Microbiology. 10. 18–18. 17 indexed citations
15.
Xu, Wenping, Jinpei Liu, Jifeng Feng, et al.. (2019). miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy. Gut. 69(7). 1309–1321. 88 indexed citations
16.
Wan, Sizhe, Chenkai Huang, & Xuan Zhu. (2019). Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients. BMJ Open. 9(7). e030038–e030038. 13 indexed citations
17.
Zhang, Wang, Jie Jian, Chenkai Huang, et al.. (2019). Protective Effect of Ursolic Acid on the Intestinal Mucosal Barrier in a Rat Model of Liver Fibrosis. Frontiers in Physiology. 10. 956–956. 29 indexed citations
18.
Wan, Sizhe, et al.. (2019). Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice. Frontiers in Pharmacology. 10. 1321–1321. 50 indexed citations
19.
Huang, Chenkai, Sizhe Wan, Jiang Chen, et al.. (2019). Interaction Mechanisms Between the NOX4/ROS and RhoA/ROCK1 Signaling Pathways as New Anti- fibrosis Targets of Ursolic Acid in Hepatic Stellate Cells. Frontiers in Pharmacology. 10. 431–431. 34 indexed citations
20.
Yu, Shanshan, Biao Chen, Chenkai Huang, et al.. (2017). Ursolic acid suppresses TGF-β1-induced quiescent HSC activation and transformation by inhibiting NADPH oxidase expression and Hedgehog signaling. Experimental and Therapeutic Medicine. 14(4). 3577–3582. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongyao Liu Breakdown of academic impact, for papers by Chanbin Lee Breakdown of academic impact, for papers by Xiong Cai Breakdown of academic impact, for papers by Hsiao‐Yen Ma Breakdown of academic impact, for papers by Siwei Xia Breakdown of academic impact, for papers by Weiguang Ren Breakdown of academic impact, for papers by Mao‐xu Ge Breakdown of academic impact, for papers by Karim Hamesch Breakdown of academic impact, for papers by Yang Cheng
Rankless by CCL
2026